IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

AGOSTONI, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.462
NA - Nord America 2.343
AS - Asia 1.334
SA - Sud America 67
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 8.216
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.275
GB - Regno Unito 2.053
DE - Germania 1.046
CN - Cina 560
SE - Svezia 435
IT - Italia 279
TR - Turchia 214
VN - Vietnam 199
KR - Corea 188
UA - Ucraina 122
IE - Irlanda 117
EU - Europa 93
RU - Federazione Russa 91
NL - Olanda 87
IN - India 86
FI - Finlandia 80
FR - Francia 72
CA - Canada 67
CO - Colombia 56
GR - Grecia 27
HK - Hong Kong 18
PL - Polonia 18
SG - Singapore 16
ID - Indonesia 14
BE - Belgio 13
IR - Iran 12
BR - Brasile 9
JP - Giappone 9
YE - Yemen 6
ES - Italia 4
LT - Lituania 3
RO - Romania 3
UZ - Uzbekistan 3
AT - Austria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
IL - Israele 2
LK - Sri Lanka 2
AR - Argentina 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
DZ - Algeria 1
HR - Croazia 1
KW - Kuwait 1
MA - Marocco 1
MT - Malta 1
MU - Mauritius 1
MX - Messico 1
NG - Nigeria 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 8.306
Salva come PNG Salva come JPEG
Città #
Southend 1.891
Chandler 326
Seattle 246
Princeton 196
Wilmington 148
Beijing 139
Dublin 117
Ashburn 113
Redmond 110
Dong Ket 108
Somerville 105
Milan 82
Fairfield 78
Jacksonville 77
Sakarya 74
Nanjing 68
Odernheim 61
Des Moines 60
Mountain View 60
Ann Arbor 59
Woodbridge 59
Andover 56
Bogotá 56
Toronto 54
Houston 44
Bengaluru 42
Dearborn 37
Serra 37
Geisenheim 33
Jinan 33
Boardman 32
Seoul 29
Guangzhou 27
Hebei 27
Athens 26
Saint Petersburg 26
Berlin 25
Shenyang 25
Phoenix 23
Grafing 22
Seongnam 21
Nanchang 20
Redwood City 20
Cambridge 19
Taizhou 18
Bitonto 17
Shanghai 16
Hanover 14
Tianjin 14
Turin 14
Warsaw 14
Zhengzhou 14
Falls Church 13
Fremont 13
Pune 13
Changsha 12
Mainz 12
New York 12
Ningbo 12
San Diego 12
Brussels 10
Chongqing 10
Eitensheim 10
Jiaxing 10
Mumbai 10
Fuzhou 8
Haikou 8
Hong Kong 8
Kwai Chung 8
Hangzhou 7
Hefei 7
Lanzhou 7
Norwalk 7
Helsinki 6
Karaj 6
Kiez 6
Verona 6
Ahnsen 5
London 5
Pisa 5
Sanaa 5
Tappahannock 5
Brescia 4
Cupertino 4
Kunming 4
Montréal 4
Ottawa 4
São Paulo 4
Taiyuan 4
Tokyo 4
Chengdu 3
Detroit 3
Madras 3
Margão 3
Norsborg 3
Nürnberg 3
Philadelphia 3
Rome 3
Roxbury 3
San Jose 3
Totale 5.352
Salva come PNG Salva come JPEG
Nome #
Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin 349
Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner 215
Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema 198
Consumption of C4b-binding protein (C4BP) during in vivo activation of the classical complement pathway 174
Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies 156
Hereditary and acquired angioedema : problems and progress : proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 148
Pathogenetic and clinical aspects of C1-inhibitor deficiency 145
Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C 142
Angioedema associated with angiotensin-converting enzyme inhibitor use : outcome after switching to a different treatment 139
Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies 138
Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency 136
Fibrinolytic response in normal subjects to venous occlusion and DDAVP infusion 136
Activation of the contact system and fibrinolysis in autoimmune acquired angioedema : a rationale for prophylactic use of tranexamic acid 136
Non neutralizing antibodies to tissue type plasminogen activator in serum of acute myocardial infarction patients treated with the recombinant protein 135
Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate 135
C1 inhibitor function and anti-C1 inhibitor autoantibodies in patients with HIV type 1 infection 134
Problemi di emocoagulazione in corso di circolazione extracorporea a lungo termine 134
Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator 133
DDAVP infusion does not affect plasma levels of endothelin-1 in four normal subjects 133
Physiopathology and management of coagulation during long-term extracorporeal respiratory assistance 133
Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency) 132
Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema 131
Angioedema due to angiotensin-converting enzyme inhibitors 130
Autoimmune C1 inhibitor deficiency : report of eight patients 127
Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema 127
Idiopathic nonhistaminergic angioedema 126
Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon 126
Disseminated intravascular coagulation (DIC) during long-term bypass : incidence and clinical relevance 124
Statistical evaluation of commonly used tests for heparin monitoring 124
Bradykinin and the pathophysiology of angioedema 123
Evaluation of tests for heparin control during long-term extracorporeal circulation 123
Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease 123
L-arginine therapy in Raynaud's phenomenon? 123
Hepatic function and fibrinolysis in patients with hereditary angioedemaundergoing long-term treatment with tranexamic acid 123
Cleavage of high molecular weight kininogen in ascites and plasma of patients with cirrhosis 122
Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon 121
Hereditary angioedema: an appraisal of 104 cases 118
Bradykinin in the ascitic fluid of patients with liver cirrhosis 117
Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease 114
Side effects of long-term prophylaxis with attenuated-androgens in hereditary angioedema : comparison between treated and non-treated patients 113
Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angioedema 112
Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis 112
C1-inhibitor concentrate for treatment of hereditary angioedema 112
Cardioprotective effect of C1-inhibitor 107
Effect of PGI2 infusion during long term extracorporeal circulation with membrane lung in sheep 105
Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives 103
Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors 101
Intermittent therapy with danazol in hereditary angioedema 101
C1 INH concentrate in the therapy of hereditary angioedema 101
Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome 98
Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy 97
Thrombolytic treatment and complement activation 97
Clinical problems in the C1-inhibitor deficient patient 95
Plasma bradykinin levels in human chronic congestive heart failure 92
Hereditary angioneurotic oedema 91
Long-term treatment of hereditary angioedema with attenuated androgens : a survey of a 13-year experience 89
Leucotriene B4 and peptido-leucotriene levels during radiographic contrast media infusion 89
Drug-induced angioedema without urticaria 86
Local bradykinin generation in hereditary angioedema. 83
Cardiopulmonary bypass increases plasma bradykinin concentrations 83
Generation of plasmin during acute attacks of hereditary angioedema 81
Effect of treatment with 17alpha-alkylated androgens on C4 conversion products in hereditary angioedemastudied by crossed immunoelectrophoresis 79
Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with Echinococcus granulosus 79
In vitro interaction of C1-inhibitor with thrombin 78
Plasma bradykinin in angio-oedema 76
Immunoreactive precipitation of C1 inhibitor protein from plasma of normalsubjects and of patients with hereditary angioedema after isoelectric focusing 76
Hereditary angioedema 74
Influence of contact system deficiencies during cardiopulmonary bypass 70
Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass : the importance of lung exclusion 68
Hereditary and acquired C1-inhibitor deficiency : biological and clinical characteristics in 235 patients 67
In vivo study of the complement system during infusion ofradiographic contrast media 67
Replacement therapy in hereditary and acquired angioedema 64
The systemic capillary leak syndrome : appearance of interleukin-2-receptor-positivecells during attacks 64
Restriction fragment length polymorphism of the C1 inhibitor gene in hereditaryangioneurotic edema 63
Treatment of hereditary angioedema 63
Complement deficiency and antibodyprofile in survivors of meningococcal meningitis due to common serogroups in Italy 60
Nonsensemutations affect C1 inhibitor messenger RNA levels in patients with type Ihereditary angioneurotic edema 55
Totale 8.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.820
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.820
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019242 0 0 0 0 0 0 0 0 0 54 102 86
2019/2020799 103 30 26 82 21 76 60 51 162 127 48 13
2020/20211.071 71 30 69 11 84 59 45 96 87 41 234 244
2021/2022963 106 30 22 82 57 58 103 112 92 74 108 119
2022/20231.027 161 113 82 121 110 216 13 60 108 12 29 2
2023/2024303 24 44 19 14 89 48 14 27 5 19 0 0
Totale 8.754